Lysosomal cysteine cathepsins: signaling pathways in apoptosis
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Apoptosis is the major mechanism by which eukaryotic organisms eliminate potentially dangerous, superfluous and damaged cells. Initially, nuclei and mitochondria were found to be the key organelles involved in the process. However, recent data suggest that lysosomes and the endoplasmic reticulum also play important roles in the process. A number of different stimuli were found to directly or indirectly target the lysosomal membrane, thereby inducing lysosomal permeabilization and the release of cysteine cathepsins and the aspartic protease cathepsin D into the cytosol. Once in the cytosol, cathepsins can trigger cell death by different mechanisms. Here we discuss the different signaling pathways used by lysosomal proteases to trigger apoptosis and their potential role in physiological processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626 · cited 2×
“The major cleavage sites were thus found to be Asp59 for caspase-8 (Li et al., 1998; Luo et al., 1998), -3 (Slee et al., 2000), -2 (Bonzon et al., 2006) and -15 (Eckhart et al., 2005), Asp75 for granzyme B (Barry et al., 2000) and caspase-15 (Eckhart et al., 2005), Arg65 for lysosomal extracts…”
BackgroundClassification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry, W. S., Golstein, P., Green, D. R., et al. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.150 · Cited by 3,399 · cited 1×
“An intact plasma membrane is maintained until the late stages of the process (Kroemer et al., 2005).”
BackgroundIAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · cited 2×
“…its degradation at the 26S proteasome (Breitschopf et al., 2000); (d) the anti-apoptotic members of the Bcl-2 family act at the mitochondrial level (Harada and Grant, 2003), and (e) XIAP (inhibitor of apoptosis protein) blocks inappropriately activated caspases (Salvesen and Duckett, 2002).”
BackgroundClassification of cell death: recommendations of the Nomenclature Committee on Cell Death
Kroemer, G., El-Deiry, W. S., Golstein, P., Peter, M. E., Vaux, D., Vandenabeele, P., Zhivotovsky, B., Blagosklonny, M. V., Malorni, W., Knight, R. A., et al. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401724 · Cited by 843 · cited 1×
“An intact plasma membrane is maintained until the late stages of the process (Kroemer et al., 2005).”
BackgroundLysosomal Membrane Permeabilization Induces Cell Death in a Mitochondrion-dependent Fashion
Boya, P., Andreau, K., Poncet, D., Zamzami, N., Perfettini, J.-L., Metivier, D., Ojcius, D. M., Jäättelä, M., & Kroemer, G. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021952 · Cited by 483
Boya, P., Gonzalez-Polo, R.-A., Poncet, D., Andreau, K., Vieira, H. L., Roumier, T., Perfettini, J.-L., & Kroemer, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206622 · Cited by 385 · cited 5×
“3- Aminopropanal is a weak lysosomotropic base (Li et al., 2003), whereas the lysosomotropic amine hydroxychloroquine induces a decrease in lysosomal pH gradient (Boya et al., 2003b).”
BackgroundInfluentialBax inhibition protects against free fatty acid-induced lysosomal permeabilization
Feldstein, A. E., Werneburg, N. W., Li, Z., Bronk, S. F., & Gores, G. J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00509.2005 · Cited by 174 · cited 1×
“A similar mechanism for LMP was also suggested for free fatty acids such as palmitate (Feldstein et al., 2006).”
BackgroundBivik, C. A., Larsson, P. K., Kågedal, K. M., Rosdahl, I. K., & Öllinger, K. M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700124 · Cited by 102 · cited 1×
“A number of subsequent studies confirmed the central position of Bid in lysosomal cathepsin-mediated apoptosis, although the pathways were not always the same (Guicciardi et al., 2000; Reiners et al., 2002; Caruso et al., 2004; Cirman et al., 2004; Bivik et al., 2006).”
Background
Cited by
Cysteine cathepsins: From structure, function and regulation to new frontiers
Turk, V., Stoka, V., Vasiljeva, O., Renko, M., Sun, T., Turk, B., & Turk, D. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.10.002 · Cited by 1,377
“On the other hand, cathepsins have recently attracted considerable attention as potential mediators in programmed cell death (apoptosis) [38], a key process in cancer de-”
BackgroundSelf-citationHsp70 stabilizes lysosomes and reverts Niemann–Pick disease-associated lysosomal pathology
Kirkegaard, T., Roth, A. G., Petersen, N. H. T., Mahalka, A. K., Olsen, O. D., Moilanen, I., Zylicz, A., Knudsen, J., Sandhoff, K., Arenz, C., et al. (2010) · Nature · doi:10.1038/nature08710 · Cited by 519
Regulation of apoptosis-associated lysosomal membrane permeabilization
Johansson, A.-C., Appelqvist, H., Nilsson, C., Kågedal, K., Roberg, K., & Öllinger, K. (2010) · Apoptosis · doi:10.1007/s10495-009-0452-5 · Cited by 463
Cysteine cathepsins: Cellular roadmap to different functions
Brix, K., Dunkhorst, A., Mayer, K., & Jordans, S. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.024 · Cited by 428
Lysosomes and lysosomal cathepsins in cell death
Repnik, U., Stoka, V., Turk, V., & Turk, B. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.08.016 · Cited by 404
Self-citationLiu, B., Turley, S. D., Burns, D. K., Miller, A. M., Repa, J. J., & Dietschy, J. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810895106 · Cited by 377
Lysosomal cathepsins and their regulation in aging and neurodegeneration
Stoka, V., Turk, V., & Turk, B. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.010 · Cited by 334
Self-citationNanopreparations for organelle-specific delivery in cancer
Biswas, S., & Torchilin, V. P. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.004 · Cited by 292
Protease signalling: the cutting edge
Turk, B., Turk, D., & Turk, V. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.42 · Cited by 287
Self-citationMaclean, K. H., Dorsey, F. C., Cleveland, J. L., & Kastan, M. B. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33700 · Cited by 272
Cathepsins: Key modulators of cell death and inflammatory responses
Conus, S., & Simon, H.-U. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.07.041 · Cited by 227
Cathepsin L, target in cancer treatment?
Lankelma, J. M., Voorend, D. M., Barwari, T., Koetsveld, J., Van der Spek, A. H., De Porto, A. P. N. A., Van Rooijen, G., & Van Noorden, C. J. F. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.11.016 · Cited by 180
Edgington, L. E., Verdoes, M., & Bogyo, M. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2011.10.012 · Cited by 169
The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases
Nixon, R. A. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140443 · Cited by 149
“LMP is a well-reviewed topic (Boya and Kroemer, 2008; Groth-Pedersen and Jaattela, 2013; Johansson et al., 2010; Repnik et al., 2014; Stoka et al., 2007) and the detailed mechanisms of LMP interface with mechanisms of cell death beyond the scope of this review.”
BackgroundChapter Nine Lysosomes in Apoptosis
Ivanova, S., Repnik, U., Boji, L., Petelin, A., Turk, V., & Turk, B. (2008) · Methods in Enzymology · doi:10.1016/s0076-6879(08)01409-2 · Cited by 69
Self-citationRNA-seq and network analysis reveal unique glial gene expression signatures during prion infection
Carroll, J. A., Race, B., Williams, K., Striebel, J., & Chesebro, B. (2020) · Molecular Brain · doi:10.1186/s13041-020-00610-8 · Cited by 66
(2015) · PubMed · Cited by 18
Metadata
- Authors
- Stoka, V., Turk, V., & Turk, B.
- Venue
- bchm
- Publisher
- Walter de Gruyter GmbH
- Published
- 2007-06-01
- Volume
- 388
- Issue
- 6
- Pages
- 555-560
- ISSN
- 1431-6730 (ISSN-L)
- 1437-4315
- OpenAlex
- W1964307104
- Cited by
- 141
- References
- 8
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.